Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
77.25 GBX | +2.05% | -0.26% | -10.54% |
Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
Mar. 12 | Target Healthcare interim net asset value and contractual rent grow | AN |
Sales 2024 * | 71.4M 89.36M | Sales 2025 * | 73.17M 91.57M | Capitalization | 470M 588M |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.1M | Net income 2025 * | 65M 81.35M | EV / Sales 2024 * | 9.81 x |
Net Debt 2024 * | 231M 289M | Net Debt 2025 * | 256M 321M | EV / Sales 2025 * | 9.92 x |
P/E ratio 2024 * |
7.21
x | P/E ratio 2025 * |
7.19
x | Employees | - |
Yield 2024 * |
7.53% | Yield 2025 * |
7.71% | Free-Float | 99.9% |
1 day | +2.05% | ||
1 week | -0.26% | ||
Current month | -8.31% | ||
1 month | -6.99% | ||
3 months | -8.75% | ||
6 months | +9.04% | ||
Current year | -10.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 74 | - | |
Gordon Bland
DFI | Director of Finance/CFO | 45 | - |
John Flannelly
CIO | Chief Investment Officer | 49 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Vince Niblett
BRD | Director/Board Member | - | 21-08-24 |
Richard Cotton
BRD | Director/Board Member | 68 | 22-10-31 |
Michael Brodtman
BRD | Director/Board Member | 64 | 22-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 77.2 | +1.98% | 320 022 |
24-04-25 | 75.7 | -1.17% | 1,164,473 |
24-04-24 | 76.6 | -2.05% | 583,103 |
24-04-23 | 78.2 | +0.13% | 617,015 |
24-04-22 | 78.1 | +0.90% | 844,397 |
Delayed Quote London S.E., April 26, 2024 at 07:06 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.54% | 587M | |
+2.19% | 27.17B | |
+6.08% | 24.59B | |
+1.08% | 21.12B | |
-0.29% | 15.87B | |
-11.02% | 14.82B | |
-5.40% | 14.85B | |
-0.56% | 13.1B | |
-0.84% | 12.5B | |
-13.88% | 11.33B |
- Stock Market
- Equities
- THRL Stock